On June 6, 2026, Nurix Therapeutics, Inc. signed a License and Collaboration Agreement with F. Hoffmann-La Roche Ltd. and Genentech, Inc
Quick answer
Nurix Therapeutics Enters License and Collaboration Agreement with Roche (June 8, 2026). Nurix Therapeutics is based in Brisbane, California, United States.
What agreement did Nurix Therapeutics announce on June 8, 2026?
On June 6, 2026, Nurix Therapeutics, Inc. signed a License and Collaboration Agreement with F. Hoffmann-La Roche Ltd. and Genentech, Inc
What does Nurix Therapeutics do?
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases.
Where is Nurix Therapeutics based?
Nurix Therapeutics is based in Brisbane, California, United States.
Source: Fundz verified event record.
Company Information
Company
Nurix Therapeutics
Location
1600 Sierra Point Pkwy
Brisbane, California, United States
About
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases. The company is focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases.